Alere is alerting clinicians who use its international normalized ratio (INR) monitoring system that results in patients with certain conditions may be clinically lower than results from a laboratory test.

There is still much to be learned about the long-term effects of commonly prescribed drugs such as statins.

While statins have a clearly positive effect on cardiovascular disease risk, research suggests the role statins may have on the development of cataracts may cloud risk-benefit considerations for some patients.

iRhythm Technologies, Inc., a leading digital health care solutions company focusing on the advancement of cardiac care, today announced that it has secured a CE mark (Conformité Européenne) for the ZIO Service, enabling the company to market its long-term continuous heart monitoring solution in Europe. The company also announced its first international market entry through an exclusive agreement with CardioLogic Ltd, which will make the ZIO Service available to patients throughout the United Kingdom to improve the diagnosis of atrial fibrillation (Afib) and other cardiac arrhythmias. Financial terms were not disclosed

Adrenaline may jumpstart the heart but it might not contribute positively to survival following an out-of-hospital cardiac arrest, found a study published Dec. 9 in the Journal of the American College of Cardiology.

Many hospitals have an opportunity to curb post-PCI bleeding, based on an assessment of CathPCI Registry data that found bleeding rates were wildly variable among participating hospitals.

It could be called a bad break: Researchers hoping statins might secondarily reduce fractures in cardiovascular patients found their hopes shattered. 

Sometimes, a little reminder does a heart a world of good. Real-world patients given EHR-linked, automated reminders to refill prescriptions for statins and other heart medications had better adherence to medication and ultimately better outcomes.